Chengdu Huasun Technology Group Inc Ltd
000790
Company Profile
Business description
Chengdu Huasun Technology Group Inc Ltd is engaged in the production and distribution of traditional Chinese medicines and chemical drugs in China. The company does its business in industries such as Modern Chinese Medicine, Bio-pharmacy, Health Industry, and Building Steel Structure. The company's product consists of Sanqi tongsu capsule, Biyuanshu oral liquid, Huolishu oral liquid, and Smokeless moxa stick.
Contact
1168 Fuxin Avenue, High-tech Zone (West District)
No. 101, 1st Floor, Building 2
Sichuan
Chengdu611731
CHNT: +86 2866616680
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
727
Stocks News & Analysis
stocks
AI driving growth for ASX tech share
ASX tech share raises funds to facilitate customer AI spend.
stocks
OpenAI is going public as the worst value among its peers
Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks
Wide moat healthcare leader remains undervalued
ASX healthcare giant expected to see uptick in demand from emerging markets.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,824.80 | 67.50 | 0.77% |
| CAC 40 | 8,243.00 | 43.71 | 0.53% |
| DAX 40 | 24,616.41 | 0.19 | 0.00% |
| Dow JONES (US) | 50,919.98 | 133.97 | 0.26% |
| FTSE 100 | 10,286.19 | 87.01 | -0.84% |
| HKSE | 24,565.90 | 91.16 | -0.37% |
| NASDAQ | 25,755.04 | 174.62 | -0.67% |
| Nikkei 225 | 65,416.63 | 1,392.03 | 2.17% |
| NZX 50 Index | 13,204.08 | 165.84 | 1.27% |
| S&P 500 | 7,389.15 | 16.58 | -0.22% |
| S&P/ASX 200 | 8,604.20 | 70.70 | 0.83% |
| SSE Composite Index | 4,010.03 | 50.69 | 1.28% |